ColoSense Test Included in NCCN Colorectal Cancer Guidelines
June 3, 2025
ColoSense is recommended as a first-line test for colorectal cancer screening, with a three-year screening interval Geneoscopy, Inc., a life sciences company focused on developing diagnostic